Literature DB >> 6309288

Increased respiratory burst in myeloperoxidase-deficient monocytes.

R M Locksley, C B Wilson, S J Klebanoff.   

Abstract

Studies of the respiratory burst in myeloperoxidase (MPO) deficient monocytes were undertaken to assess the physiologic consequence of the absence of MPO in these cells. As previously demonstrated with neutrophils, MPO-deficient monocytes had a greater initial rate, duration, and total superoxide production in response to phagocytosis of zymosan than did normal monocytes. Introduction of purified eosinophil peroxidase (EPO) into the phagosome by binding the enzyme to the surface of the zymosan particles changed the hypermetabolic characteristics of superoxide production in MPO-deficient cells to more closely resemble normal cells, but had no effect on superoxide generation by the normal monocytes. Further, inactivation of the bound EPO before ingestion restored the supranormal respiratory burst by the MPO-deficient cells. Iodination by MPO-deficient monocytes was significantly depressed as compared to normal monocytes following the ingestion of zymosan (1.9 versus 10.1 nmole I-/10(7) monocytes/30 min; p less than 0.01). In contrast, iodination was markedly augmented in MPO-deficient cells compared to normal cells after ingestion of zymosan coated with EPO (208 versus 70 nmole I-/10(7) monocytes/30 min; p less than 0.005), presumably reflecting the greater amounts of hydrogen peroxide formed by MPO-deficient cells. There were no differences in the levels of endogenous scavengers of reactive oxygen products (catalase, superoxide dismutase, glutathione peroxidase and reductase, and total glutathione) in MPO-deficient and normal monocytes that would account for the enhanced respiratory burst of MPO-deficient cells. These findings support a role for peroxidase in the termination of the respiratory burst of monocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309288

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

Review 2.  How neutrophils kill microbes.

Authors:  Anthony W Segal
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  Imaging of innate immunity activation in vivo with a redox-tuned PET reporter.

Authors:  Federica Pisaneschi; Seth T Gammon; Vincenzo Paolillo; Sarah A Qureshy; David Piwnica-Worms
Journal:  Nat Biotechnol       Date:  2022-02-21       Impact factor: 68.164

4.  Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium.

Authors:  Ghassan J Maghzal; Katie M Cergol; Sudhir R Shengule; Cacang Suarna; Darren Newington; Anthony J Kettle; Richard J Payne; Roland Stocker
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

5.  Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin.

Authors:  Kai Kessenbrock; Leopold Fröhlich; Michael Sixt; Tim Lämmermann; Heiko Pfister; Andrew Bateman; Azzaq Belaaouaj; Johannes Ring; Markus Ollert; Reinhard Fässler; Dieter E Jenne
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 6.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28

7.  Viricidal effect of stimulated human mononuclear phagocytes on human immunodeficiency virus type 1.

Authors:  M J Chase; S J Klebanoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration.

Authors:  V H Perry; M C Brown; S Gordon
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.